Medical devicemaker Getinge saw its core profit reduce by half in its second quarter as quality and supply problems "overshadowed" monetary growth, the company said July 18.
The issues were focused in two of its product categories: cardiac assist and cardiopulmonary. In June, the company predicted possible breaches of sterile packaging could negatively affect its " sales, mix and earnings for the rest of the year."
During the second quarter, net sales increased 1.3 percent during the quarter, but the number of orders fell 4.5 percent.